Mesa Laboratories (MLAB) Earns Daily News Sentiment Score of 0.11

News articles about Mesa Laboratories (NASDAQ:MLAB) have trended somewhat positive this week, according to Accern Sentiment Analysis. The research group identifies positive and negative news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Mesa Laboratories earned a media sentiment score of 0.11 on Accern’s scale. Accern also gave headlines about the medical instruments supplier an impact score of 46.2043846308749 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

MLAB has been the topic of several research reports. BidaskClub lowered Mesa Laboratories from a “hold” rating to a “sell” rating in a research note on Monday, July 31st. TheStreet lowered Mesa Laboratories from a “b” rating to a “c+” rating in a research note on Monday, July 31st. Finally, Zacks Investment Research lowered Mesa Laboratories from a “buy” rating to a “strong sell” rating in a research note on Thursday, August 3rd.

Shares of Mesa Laboratories (MLAB) traded up 3.66% during midday trading on Friday, reaching $160.83. The company’s stock had a trading volume of 16,613 shares. The company has a market cap of $604.40 million, a P/E ratio of 57.81 and a beta of 0.49. Mesa Laboratories has a 12-month low of $109.14 and a 12-month high of $169.81. The stock’s 50-day moving average price is $147.60 and its 200-day moving average price is $143.52.

Mesa Laboratories (NASDAQ:MLAB) last posted its quarterly earnings results on Monday, July 31st. The medical instruments supplier reported $0.39 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.56 by ($0.17). Mesa Laboratories had a return on equity of 16.58% and a net margin of 11.31%. The company had revenue of $22.67 million during the quarter, compared to analyst estimates of $22.90 million. On average, analysts expect that Mesa Laboratories will post $2.75 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 15th. Shareholders of record on Thursday, November 30th will be given a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 0.40%. The ex-dividend date of this dividend is Wednesday, November 29th. Mesa Laboratories’s payout ratio is 22.94%.

In other Mesa Laboratories news, Director H Stuart Campbell sold 1,000 shares of the company’s stock in a transaction dated Friday, August 4th. The shares were sold at an average price of $143.09, for a total transaction of $143,090.00. Following the completion of the sale, the director now directly owns 47,976 shares in the company, valued at $6,864,885.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have sold 8,610 shares of company stock valued at $1,176,809 over the last 90 days. Corporate insiders own 15.70% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This report was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this report on another publication, it was illegally stolen and republished in violation of US & international copyright and trademark legislation. The original version of this report can be accessed at https://www.dispatchtribunal.com/2017/10/27/mesa-laboratories-mlab-receiving-somewhat-positive-media-coverage-analysis-finds.html.

About Mesa Laboratories

Mesa Laboratories, Inc is focused primarily on quality control products and services. The Company operates through four segments: Instruments, Continuous Monitoring, Biological Indicators and Cold Chain. The Instruments Division designs, manufactures and markets quality control instruments and disposable products.

Insider Buying and Selling by Quarter for Mesa Laboratories (NASDAQ:MLAB)

Receive News & Ratings for Mesa Laboratories Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesa Laboratories Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply